Skeletal Muscle Relaxants Flashcards

(36 cards)

1
Q

Types of Skeletal Muscle Relaxants

A

Neuromuscular blockers

  • Antagonists/ Non-depolarizing blockers
  • Agonists/ Depolarizing blockers

Spasmolytics

  • Chronic spasm agents
  • Acute spasm agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Non-depolarizing blockers (types & names)

A
  1. Benzylisoquinolines
    - Tubocurarine
    - Atracurium
    - Cisatracurium
    - Mivacurium
  2. Ammonio Steroids
    - Pancuronium
    - Rocuronium
    - Vecuronium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA of Non-depolarizing Blockers

A

Competitive antagonists

  • causes motor weakness –>
  • skeletal muscles become totally flaccid & inexcitable to stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Reversal of Non-depolarizing antagonists actions

A

Inc conc. of ACh in synapse

  • Neostigmine
  • Edrophonium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classification of Non-depolarizing Muscle relaxants based on Duration of Action

A

Short-acting
- Mivacurium

Intermediate-acting

  • Atracurium
  • Cisatracurium
  • Rocuronium
  • Vecuronium

Long-acting

  • Tubocurarine
  • Pancuronium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Excretion of Non-depolarizing blockers

A
  1. Kidney – Long Half-life – Long Duration of Action

2. Liver – Short Half life – Short Duration of Action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Elimination mechanism & DOA of Benzylisoquinolones

A
  1. Mivacurium - Plasma pseudocholinesterase - 15 mins
  2. Atracurium - Enzymatic & Non-enzymatic ester hydrolysis - 45 mins
  3. Cisatracurium - Spontaneous (80%) & renal - 45 mins
  4. Tubocurarine - Renal & hepatic - 80 mins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Elimination mechanism & DOA of Ammonio steroids

A
  1. Rocuronium - Hepatic (80%) & Renal - 30 mins
  2. Vecuronium - Hepatic (80%) & Renal - 45 mins
  3. Pancuronium - Renal (80%) & Hepatic - 90 mins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metabolism & AEs of Atracurium

A

Metabolite - Laudanosine

  • Hypotension
  • Seizures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metabolism & AEs of Cisatracurium (Stereoisomer of Atracurium)

A

Metabolite = Laudanosine (much less than Atracurium)
- less histamine release

Replaced Atracurium in clinical practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Metabolism of Mivacurium

A

Hydrolysis (inactivation) by Butyrylcholinesterase

  • not dependent on kidney or liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metabolism & uses of Rocuronium

A
  • Most rapid onset non-depolarizing blockers

- Used as an alternative to Succinylcholine for rapid sequence intubation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Depolarizing blockers (names)

A

-Succinylcholine (2 ACh molecules linked end-to-end)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA of Succinylcholine

A

Activates Nicotinic receptors –> depolarization of junction –> Unresponsiveness to additional impulses

  • Fasciculations
  • Flaccid paralysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Time of onset & Duration of action of Succinylcholine

A

Time of onset = < 1 min

Duration of action = 5-10 mins (bc of rapid hydrolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Metabolism/ Hydrolysis of Succinylcholine

A

Rapid hydrolysis by plasma Pseudocholinesterase

  • not effectively metabolized by Acetylcholinesterase
17
Q

Polymorphisms of Butyrylcholinesterase

A

Muscle blockade may be prolonged in pts. w/ abnormal variant of Butyrylcholineserase that uses Succinylcholine or Mivacurium.

18
Q

Treatment of pts. w/ Abnormal Butyrylcholinesterase & Succinylcholine or Mivacurium use

A

Mechanical ventilation until normal muscle function returns

19
Q

Pharmacokinetics of Neuromuscular blockers

A
  • Highly polar & poorly soluble in lipids
  • IV or IM use always (inactive if given by mouth)
  • Poor membrane penetration
  • Do not enter cells or cross the BBB
20
Q

AEs of Benzylisoquinolines

A

Hypotension

- Histamine release & ganglion blockade

21
Q

AEs of Ammonio steroids

A

Tachycardia –> Arrhythmias
- Muscarinic blockade (cardiac M2 receptors)

Pancuronium - Moderate tachycardia
- usually not a problem

22
Q

Drugs that causes Histamine release

A

Tubocurarine

Lesser extent

  • Mivacurium
  • Atracurium
23
Q

Drugs that cause Ganglion blockade

A

Tubocurarine
-block nicotinic receptors of Autonomic ganglia & adrenal medulla –>

  • Hypotension
  • Tachycardia
24
Q

AEs of Tubocurarine

A
  • Hypotension

- Tachycardia

25
AEs of Depolarizing blockers (Succinylcholine)
Activates all autonomic cholinoceptors (nicotinic in SNS & PSNS and Muscarinic in heart) - Bradycardia - Histamine release - Muscle pain - Hyperkalemia - Inc. IOP - Inc intragastric pressure - Malignant hyperthermia
26
CNS AEs of Muscle relaxants
NONE | - Unable to cross BBB
27
Drugs that enhance Neuromuscular blockers
- Inhaled anesthetics - Aminoglycosides - Tetracycline
28
Diseases or Age that increase drug response
- Myasthenia gravis | - Advanced age - Dec drug clearance
29
Disease that Dec drug response
Severe burns & UMN disease - Proliferation of extra-junctional receptors - Drug resistance
30
Contraindication of Depolarizing Blockers
1. Hx of malignant hyperthermia 2. Hx of skeletal muscle myopathies 3. Major burns 4. Multiple traumas 5. Denervation of skeletal muscles 6. UMN injury
31
Uses of Neuromuscular Blockers
1. Adjuvants in surgical anesthesia | 2. Succinylcholine - Endotracheal intubation & ECT
32
Reversal of Non-depolarizing Blockers
1. Neostigmine | 2. edrophonium
33
Bradycardia prevention
1. Atropine | 2. Glycopyrrolate
34
Spasmolytic drug classes
Chronic use - CNS acting - Skeletal muscle acting Acute use - Centrally acting/ Brainstem
35
Chronic use Spasmolytic Drugs (classes & names)
1. Chronic use CNS action - Diazepam (GABAa) - Baclofen (GABA agonists @ GABAb) - Tizanidine (a2-adrenoceptor agonist) Skeletal muscle action - Dantrolene (Dec Ca release from SR) - Botulism toxin
36
Acute use Spasmolytic drugs
Cyclobenzaprine (prototype) - centrally acting (level of brainstem) - use for relief of acute muscle spasm caused by local trauma or strain - Strong anti-muscarinic side effects - structurally related to TCAs